2024-09-05 20:14:50
Didier Raoult gives a press conference on Covid-19 at the Marseille University Hospital Institute (IHU) on April 20, 2022. CHRISTOPHE SIMON / AFP
The Assistance publique-Hôpitaux de Marseille and the Fondation Méditerranée Infection have reported to the National Agency for the Safety of Medicines and Health Products (ANSM) a new publication deemed problematic by the controversial professor Didier Raoult, Agence France-Presse learned from the APHM on Thursday, September 5. Confirming information from the Point.
This report follows the publication of an article co-signed by Didier Raoult, former head of the Mediterranean Infection University Hospital Institute (IHU) in Marseille, and one of his former close collaborators, Philippe Brouqui, in the August 2024 edition of the journal Acta Scientific Microbiology. This article, based on data from 1,276 Covid-19 patients treated at the IHU, some of whom were treated with hydroxychloroquine, claims to once again demonstrate the effectiveness of this controversial treatment promoted by Professor Raoult.
Read the investigation: Article reserved for our subscribers Didier Raoult: revelations about a scientific deviation
Add to your selections
In their letter, the APHM and the Mediterranean Infection Foundation, which oversees the IHU, “report” and “dissociate” of this article whose methodology is based on “the use of patient data and unauthorized research”specified the APHM. According to the establishment, this report was decided in a “logic of return to normal” at the IHU since the departure of Professor Raoult, now retired.
The ANSM had taken legal action in November 2023 after the publication of another study co-signed by Professor Raoult, which had not obtained the mandatory authorizations. The former head of the IHU and his team are suspected of having conducted several studies “wild” at the IHU during the SARS-CoV-2 coronavirus epidemic
Read also: Article reserved for our subscribers At the IHU in Marseille, the poisonous legacy of Didier Raoult
Add to your selections
Reuse this content
1725709127
#publication #Professor #Didier #Raoult #reported #health #authorities
Table of Contents
The Controversial Career of Didier Raoult: Hydroxychloroquine and Questionable Research Methods
Didier Raoult, a French doctor, has been at the center of controversy for his promotion of hydroxychloroquine as a treatment for Covid-19. Despite his claims of its effectiveness, many in the medical community have questioned his methodology and accused him of conducting unauthorized clinical trials.
Raoult gained international attention in 2020 for his claims that hydroxychloroquine was a 100% effective treatment for Covid-19 [[3]]. He became a science star overnight, with his research being touted by even former US President Donald Trump. However, his research methods were soon called into question, with many accusing him of cherry-picking data and ignoring established scientific protocols.
In recent years, Raoult has faced criticism from French medical bodies for his research methods. In May 2023, he was slammed by researchers for conducting what they called the ”largest unauthorized clinical trial ever” [[2]]. The French medical community has been vocal in its criticism of Raoult, with many calling for him to be punished for his actions.
The latest controversy surrounding Raoult involves a new publication in which he claims to demonstrate the effectiveness of hydroxychloroquine in treating Covid-19 patients. However, the Assistance publique-Hôpitaux de Marseille and the Fondation Méditerranée Infection have reported the publication to the National Agency for the Safety of Medicines and Health Products (ANSM) due to its questionable methodology [[1]].
The publication, which was co-authored by Raoult and one of his former collaborators, is based on data from 1,276 Covid-19 patients treated at the Mediterranean Infection University Hospital Institute (IHU) in Marseille. However, the APHM and the Mediterranean Infection Foundation have distanced themselves from the publication, citing the use of patient data and unauthorized research.
Raoult’s career has been marked by controversy, and this latest incident is just another example of his questionable research methods. Despite his claims of being a maverick and a challenger of established scientific orthodoxy, many see him as a dangerous influence who has undermined trust in the scientific community.
the controversy surrounding Didier Raoult and his promotion of hydroxychloroquine serves as a reminder of the importance of rigorous scientific research and the need for accountability in the medical community. As the world continues to grapple with the Covid-19 pandemic, it is more important than ever that we rely on evidence-based research and reject questionable claims that can put lives at risk.
Keywords: Didier Raoult, hydroxychloroquine, Covid-19, questionable research methods, French medical community, controversy.
The Controversial Career of Didier Raoult: Hydroxychloroquine and Questionable Research Methods
Didier Raoult, a French doctor, has been at the center of controversy for his promotion of hydroxychloroquine as a treatment for Covid-19. Despite his claims of its effectiveness, many in the medical community have questioned his methodology and accused him of conducting unauthorized clinical trials.
Raoult gained international attention in 2020 for his claims that hydroxychloroquine was a 100% effective treatment for Covid-19 [[3]]. He became a science star overnight, with his research being touted by even former US President Donald Trump. However, his research methods were soon called into question, with many accusing him of cherry-picking data and ignoring established scientific protocols.
In recent years, Raoult has faced criticism from French medical bodies for his research methods. In May 2023, he was slammed by researchers for conducting what they called the “largest unauthorized clinical trial ever” [[2]]. The French medical community has been vocal in its criticism of Raoult, with many calling for him to be punished for his actions.
The latest controversy surrounding Raoult involves a new publication in which he claims to demonstrate the effectiveness of hydroxychloroquine in treating Covid-19 patients. However, the Assistance publique-Hôpitaux de Marseille and the Fondation Méditerranée Infection have reported the publication to the National Agency for the Safety of Medicines and Health Products (ANSM) due to its questionable methodology [[1]].
The publication, which was co-authored by Raoult and one of his former collaborators, is based on data from 1,276 Covid-19 patients treated at the Mediterranean Infection University Hospital Institute (IHU) in Marseille. However, the APHM and the Mediterranean Infection Foundation have distanced themselves from the publication, citing the use of patient data and unauthorized research.
Raoult’s career has been marked by controversy, and this latest incident is just another example of his questionable research methods. Despite his claims of
